The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jan. 16, 2018
Filed:
Mar. 25, 2014
Applicant:
Lg Chem, Ltd., Seoul, KR;
Inventors:
Seok Goo Cho, Seoul, KR;
Na Youn Kim, Seoul, KR;
Eun Jung Kim, Seoul, KR;
Keon Il Im, Seoul, KR;
Jung Yeon Lim, Seoul, KR;
Eun Joo Jeon, Seoul, KR;
Assignee:
LG CHEM, LTD., Seoul, KR;
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 31/427 (2006.01); A61K 31/445 (2006.01); A61K 31/5377 (2006.01); A61K 31/675 (2006.01); A61K 31/541 (2006.01); A61K 39/395 (2006.01); A61K 45/06 (2006.01); A61K 31/203 (2006.01); A61K 31/54 (2006.01); C07K 16/28 (2006.01); A61K 35/17 (2015.01); A61K 38/18 (2006.01); C12N 5/0783 (2010.01); A61K 35/12 (2015.01);
U.S. Cl.
CPC ...
A61K 31/541 (2013.01); A61K 31/203 (2013.01); A61K 31/54 (2013.01); A61K 35/17 (2013.01); A61K 38/1841 (2013.01); A61K 39/3955 (2013.01); A61K 45/06 (2013.01); C07K 16/2809 (2013.01); C07K 16/2818 (2013.01); C12N 5/0637 (2013.01); A61K 2035/122 (2013.01); C12N 2501/15 (2013.01); C12N 2501/385 (2013.01); C12N 2501/51 (2013.01); C12N 2501/515 (2013.01); C12N 2501/999 (2013.01);
Abstract
The present invention relates to new medical use of (tetrahydropyran-4-yl)-[2-phenyl-5-(1,1-dioxo-thiomorpholine-4-yl)methyl-1H-indol-7-yl]amine, and more particularly, to a pharmaceutical composition containing the compound as an active ingredient, which is used for inhibiting an immune response, and/or for inducing differentiation into regulator T cells from undifferentiated T cells and/or promoting proliferation of regulator T cells.